Jack | amatica health Profile picture
ex Aerospace Engineer, now ME/CFS & LC patient researcher and cofounder @amaticahealth
Apr 11 11 tweets 3 min read
New Research Post 🔬❕

47.1% of ME/CFS & Long COVID patients had elevated ANG II compared to all controls.

Correlation between ANG II and NEFL (P<0.0001), potentially linking ANGII levels with neuroinflammation

🧵👇🏻 Image
Image
Ang II is part of the renin–angiotensin–aldosterone system (RAAS). It raises blood pressure, tells your body to retain salt & water, and boosts thirst.

It’s essential for survival — but too much of it can be detrimental
Apr 2 7 tweets 2 min read
The most common question I get as a researcher:

“Do you think ME/CFS and Long Covid are treatable?”

My short answer: Yes.
My long answer: Read on. We constantly see anecdotes of recovery.
And interestingly, many of them involve the same categories of drugs:

— Antivirals
— Immunosuppressives
— Benzos
— Anticoagulants
— Metabolic drugs (like Metformin)
— ARBs

Etc.
Mar 25 10 tweets 4 min read
New Results Article - Elevated PINK1 in ME/CFS & Long COVID 🔬❕

Finally finished the article breaking down our PINK1 findings in patients:



PINK1 is a protein key to mitochondrial quality control and mitophagy (recycling of the mitochondria)

🧵 ⬇️ amaticahealth.com/blog/pink1-ele…Image
Image
What does PINK1 do?

PINK1 normally tags damaged mitochondria for recycling by recruiting PARKIN. When mitochondria malfunction, PINK1 accumulates, signaling the cell to clear out the damage and restore energy balance.
Mar 21 14 tweets 4 min read
A Unifying Theory to Resolve the Renin-Aldosterone Paradox, Low Cortisol, and Low Blood Volume in POTS, ME/CFS, and Long COVID🔬

TGF-β1–Mediated Adrenal Suppression

My theory on what is going on 🧵👇🏻 Image Normally, if blood volume is low, the body should ramp up renin & aldosterone to retain salt & water.

But in POTS, ME/CFS & Long COVID, these hormones stay low or normal, despite clear signs of low blood volume.

This is known as the “renin-aldosterone paradox”
Mar 10 7 tweets 2 min read
Just a reminder. We are accepting patients worldwide for batch 2 of our 31 marker ME/CFS and Long COVID patient funded blood panel



Cost is £1125 per patient & you get your results & research surrounding them alongside

The panel covers major systems 👇🏻 amaticahealth.com/me-cfs-long-co…Image The markers cover different systems implicated in ME & LC

- mitochondria
- vascular
- neuro inflammation
- immune system
- virus related
- neurochemical
- exercise intolerance
- mast cells

And more
Feb 28 8 tweets 2 min read
Hypothesis breakdown - Pseudo Hypoxia 1️⃣

Pseudo-hypoxia is where cells behave as if they’re oxygen-starved even when O₂ is normal

In ME/CFS & Long COVID, cells can’t meet energy demands through regular aerobic respiration

🧵 👇🏻

{text} = simplified In ME/CFS, mitochondria—especially Complex V—struggle to synthesize ATP efficiently, meaning normal oxygen levels don’t yield enough energy.

{cell’s energy factories aren’t working well, so they don’t produce enough power}
Feb 26 15 tweets 3 min read
ChatGPT Deep Research response analysis🔬

 “Hypoxia & Mitochondrial Dysfunction in Post‑Viral fatigue Syndromes.” 

I fed deep research 10 key papers, plus prompted to find additional sources and look into why HIF‑1α and PINK1 are so closely linked in ME/CFS and Long COVID 🧵 Image Both ME/CFS and Long COVID patients show problems with energy production and inflammation. 

Research finds that HIF‑1α (which signals low-oxygen stress) is raised in a subset of patients, but not as a disease significantly and PINK1 (which marks damaged mitochondria) is significantly elevated as a disease population (p <  0.0171 ), but with an evident sub population showing a notable increase compared to the control and other patients 

Hif1a and PINK1 strongly correlated (p < 0.0001)

Research from @amaticahealthImage
Image
Image
Image
Feb 18 6 tweets 3 min read
New results post 🔬❕

Our latest findings on Neurofilament Light Chain (NEFL) levels in ME/CFS and Long COVID patients are now released! 🧠



@amaticahealth

🧵 amaticahealth.com/blog/nefl/Image
Image
Image
🔬 Key Highlights:

• No overall difference in NEFL levels between patients and controls (P=0.7171)

Potential subgroups identified:

• 20% of patients elevated NEFL vs control

• 30% of patients low NEFL vs control